Blockhaus Christian, List Stephan, Waibler Hans-Peter, Gülker Jan-Erik, Klues Heinrich, Bufe Alexander, Seyfarth Melchior, Koektuerk Buelent, Shin Dong-In
Heart Centre Niederrhein, Department of Cardiology, Helios Clinic Krefeld, 47805 Krefeld, Germany.
Witten-Herdecke University, 58455 Witten, Germany.
J Clin Med. 2021 Nov 22;10(22):5435. doi: 10.3390/jcm10225435.
In patients with reduced left ventricular ejection fraction (LVEF) who are at risk of sudden cardiac death, a wearable cardioverter-defibrillator (WCD) is recommended as a bridge to the recovery of LVEF or as a bridge to the implantation of a device. In addition to its function to detect and treat malignant arrhythmia, WCD can be used via an online platform as a telemonitoring system to supervise patients' physical activity, compliance, and heart rate.
We retrospectively analyzed 173 patients with regard to compliance and heart rate after discharge.
Mean WCD wearing time was 59.75 ± 35.6 days; the daily wearing time was 21.19 ± 4.65 h. We found significant differences concerning the patients' compliance. Men showed less compliance than women, and younger patients showed less compliance than patients who were older. Furthermore, we analyzed the heart rate from discharge until the end of WCD prescription and found a significant decrease from discharge to 4, 8, or 12 weeks.
WCD can be used as a telemonitoring system to help the involved heart failure unit or physicians attend to and adjust the medical therapy. Furthermore, specific patient groups should be educated more intensively with respect to compliance.
对于左心室射血分数（LVEF）降低且有心脏性猝死风险的患者，推荐使用可穿戴式心脏复律除颤器（WCD）作为LVEF恢复的桥梁或作为植入设备的桥梁。除了检测和治疗恶性心律失常的功能外，WCD还可通过在线平台用作远程监测系统，以监督患者的身体活动、依从性和心率。
我们回顾性分析了173例患者出院后的依从性和心率情况。
WCD平均佩戴时间为59.75±35.6天；每日佩戴时间为21.19±4.65小时。我们发现患者的依从性存在显著差异。男性的依从性低于女性，年轻患者的依从性低于老年患者。此外，我们分析了从出院到WCD处方结束时的心率，发现从出院到4周、8周或12周心率显著下降。
WCD可用作远程监测系统，以帮助相关的心力衰竭治疗单元或医生关注并调整药物治疗。此外，应针对特定患者群体加强依从性教育。
